{
}
UBS has maintained its "Buy" rating for Fresenius, setting a target price of 40 euros. Analyst Graham Doyle highlighted the company's focus on the Helios Deutschland Performance Program and the positive impact of biosimilars, alongside updates regarding its reduced stake in Fresenius Medical Care.
UBS AG maintains a "Buy" rating for Fresenius SE, setting a target price of €40, as the company navigates various factors impacting its annual targets, including the Helios Deutschland Performance Program and biosimilars. The share price rose by 3.0% to €40.59, reflecting a 21.0% increase since the start of 2025, with a Q1 2025 results announcement scheduled for May 7, 2025.
UBS has maintained its "buy" rating for Fresenius, setting a target price of 40 euros. The medical group's investor relations highlighted key factors influencing annual targets, including the Helios Germany Performance Program and the positive impact of biosimilars. Additionally, Fresenius provided insights on its future stake in Fresenius Medical Care following a recent reduction in holdings.
UBS has maintained a "Neutral" rating for Fresenius Medical Care (FMC) with a target price of 39 euros. Analyst Graham Doyle expressed concerns regarding the company's margins in his commentary on the European medical technology sector's reporting season.
UBS AG has maintained a "Neutral" rating for Fresenius Medical Care (FMC) with a target price of 39 euros, highlighting concerns over margins. As of 10:47 a.m., FMC shares were nearly unchanged at EUR 48.08, indicating an 18.89% downside potential relative to the target price. The stock has risen 8.9% since the start of 2025, with Q4 2024 financial results expected on February 25, 2025.
UBS has maintained a 'Neutral' rating for Fresenius Medical Care (FMC) with a price target of 39 euros. Analyst Graham Doyle highlighted the company's focus on margins amid the European medical technology sector's reporting season. As of January 31, FMC shares traded at approximately 48.16 euros, reflecting a slight increase.
UBS has maintained a "Neutral" rating for Fresenius Medical Care (FMC) with a target price of 39 euros. Analyst Graham Doyle expresses skepticism about the medical technology sector, noting that his sales and earnings forecasts for 2025 fall below consensus estimates for 10 of the 17 stocks he covers.
Fresenius Medical Care AG, a Germany-based renal dialysis institute, specializes in providing dialysis care and related services for individuals with end-stage renal disease (ESRD). The company develops and manufactures a variety of healthcare products, including hemodialysis machines, dialyzers, and renal drugs, while also supplying its own and other dialysis clinics with essential products.
Fresenius Medical Care AG, a German-based renal dialysis institute, specializes in providing dialysis care and related services for individuals with end-stage renal disease (ESRD). The company develops and manufactures a wide range of healthcare products, including hemodialysis machines, dialyzers, and renal pharmaceuticals, while also supplying products to its own dialysis centers and other service providers.
The global Hi-Tech Medical Devices Market is experiencing significant growth driven by technological advancements, changing consumer preferences, and a focus on sustainability. Key objectives include forecasting market size across regions, analyzing growth factors, and identifying opportunities for stakeholders. Major players in the market include Medtronic, Abbott Laboratories, and Johnson & Johnson, with a comprehensive analysis of competitive dynamics and market trends provided in the research report.
Fresenius Medical Care AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains buy rating for fresenius with target price of 40 euros
23:34 05.03.2025
ubs maintains buy rating for fresenius se with target price of 40 euros
18:13 05.03.2025
ubs maintains buy rating for fresenius with 40 euro target price
17:20 05.03.2025
UBS maintains neutral rating for Fresenius Medical Care with 39 euro target
11:11 31.01.2025
ubs maintains neutral rating for fresenius medical care with target price of 39 euros
11:04 31.01.2025
ubs maintains neutral rating for fresenius medical care with target at 39 euros
10:11 31.01.2025
ubs maintains neutral rating for fresenius medical care with target price of 39 euros
11:25 26.11.2024
Fresenius Medical Care maintains neutral rating amid dialysis service developments
11:17 26.11.2024
Fresenius Medical Care Expands Dialysis Services and Healthcare Product Offerings
11:13 26.11.2024
hi-tech medical devices market poised for growth driven by innovation and sustainability
Medtronic
Johnson & Johnson
Philips Healthcare
Siemens Healthineers AG
Baxter International Inc.
Abbott Laboratories
Edwards Lifesciences Corporation
Hologic, Inc.
DexCom, Inc.
Fresenius Medical Care AG
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company
Varian Medical Systems
Boston Scientific Corporation
Zimmer Biomet Holdings, Inc.
Intuitive Surgical, Inc.
Illumina, Inc.
St. Jude Medical, Atrial Fibrillation Division Inc.
Stryker Corporation
GE HealthCare Technologies Inc.
USA
DEU
ITA
MEX
ARG
AUS
ZAF
IND
SAU
RUS
JPN
KOR
BRA
CAN
ARE
ESP
CHN
Brian Johnson
Jeff Stryker
Show more
05:10 26.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Global Trade Developments
Startups & Entrepreneurship
Stock Market Updates
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Supply Chain Management
Cryptocurrency Trends
Government Economic Policies
Private Equity Deals
Workplace Trends
Central Banks and Digital Currencies
Fintech Startups
CEO Changes
Central Bank Actions
Venture Capital Investments
Retail and Consumer Goods
Finance Mergers & Acquisitions
Global Financial Events
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Tencent Holdings Ltd
Google Inc.
Nikkei 225
Grab2Go AS
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Tesla, Inc.
MARA Holdings, Inc.
Cleanspark Inc
Citigroup Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Egyptian Pound
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
South Korean Won
Thai Baht
Mexican Peso
Croatian Kuna
People: